Our brilliant team of scientists and engineers strives to develop transformative immunotherapeutics through innovative technologies and creative partnerships to benefit patients with unmet needs.
George Wu
CEO & Cofounder
Scott Stromatt
Chief Medical Officer
Aude Segaliny
VP, Research and Early Development
Run Shen
Vice President, CMC
Philip Tagari
Ming Li
Robert Kiss
Capucine Baldini
Jane Gross
Lei Zheng
Join Us
